pharmaphorum

JULY 5, 2022

It can be caused by exposure to loud noises – including prolonged use of earbuds at high volumes – as well as cancer treatment, illnesses, genetic mutations, or aging. An estimated 1.57 The post Astellas teams up with UK biotech Mogrify on hearing loss project appeared first on.

In-Vivo 110

In-Vivo Bioinformatics Genetics Licensing 110

XTalks

APRIL 21, 2023

WGS remains at the core of developing personalized medicine against cancer as it provides valuable information for cancer etiology and progression. Biotech company Ultima Genomics has joined forces with Genome Insight, a bioinformatics-based biomedicine company, to overcome the caveat of cost and quality in WGS.

Genome 97

Genome Genomics Bioinformatics Genetics 97

Scienmag

JANUARY 20, 2021

Credit: Jan Zrimec/Chalmers University of Technology Pathogenic bacteria in humans are developing resistance to antibiotics much faster than expected. Now, computational research at Chalmers University of Technology, Sweden, shows that one reason could be significant genetic transfer between bacteria in our ecosystems and to humans.

Bacteria 97

Bacteria Genetics Development Research 97

Scienmag

NOVEMBER 18, 2020

Credit: SDSU For a slow-growing microbe that multiplies infrequently, Mycobacterium tuberculosis, the pathogen that causes tuberculosis (TB) has long puzzled researchers as to how it develops resistance to antibiotics so quickly, in a matter of weeks to months.

Bacterium 88

Bacterium Development Research Bioinformatics 88

Scienmag

APRIL 20, 2021

A new study challenges the presumption that all South-Eastern-Bantu speaking groups are a single genetic entity. Almost 80% of South Africans speak one of the SEB family languages as their first language.

Genetics 61

Genetics Research Bioinformatics Gene 61

Scienmag

APRIL 27, 2021

Credit: Nigel Michki Neurons result from a highly complex and unique series of cell divisions. For example, in fruit flies, the process starts with stem cells that divide into mother cells (progenitor cells), that then divide into precursor cells that eventually become neurons.

RNA 98

RNA Scientist Gene Development 98

pharmaphorum

JULY 20, 2022

The two organisations have previously collaborated on the creation of three cancer therapeutics companies, including bacterial delivery system developer Neobe therapeutics, oncolytic virus therapy company Stratosvir, and bioinformatics specialist Enedra.

Research 84

Research Bioinformatics Gene Therapy Medicine 84

Scienmag

AUGUST 25, 2020

Credit: Iliana Baums, Penn State Coral conservation efforts could get a boost from a newly developed genotyping “chip”–the first of its kind for corals.

Genotype 66

Genotype Genetics Development Research 66

Scienmag

SEPTEMBER 28, 2020

NIH-funded study points to genes that control the establishment of neural circuits during early development Credit: Courtesy of Dreamstime | ©Jarenwicklund.

Gene 74

Gene Genetics Development Research 74

Scienmag

SEPTEMBER 22, 2020

Credit: Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai Bottom Line: Given the toll that the COVID-19 pandemic has taken on people’s health and lives worldwide, it is crucial to be able to accurately predict patients’ outcomes, including their chances of mortality from the disease.

Genome 52

Genome Genomics Development Research 52

pharmaphorum

SEPTEMBER 14, 2020

Last week geneticist Dr Charles Steward shared with us his experiences of searching for a genetic cause for his children’s rare neurological diseases. If you are developing a drug, for example, for infantile epilepsy, then you need to know if your drug target is expressed in the brain and also during early development.

Genome 119

Genome Genomics Medicine Gene 119

Scienmag

JANUARY 13, 2021

Credit: Delaneau Group Thousands of genetic markers have already been robustly associated with complex human traits, such as Alzheimer’s disease, cancer, obesity, or height. A new statistical method, developed […].

Genomics 57

Genomics Genome Genotype Genetics 57

XTalks

SEPTEMBER 28, 2020

The test was developed by Resolution Bioscience and the company will run test analyses in its labs. The Resolution ctDx Lung assay was developed to offer patients and clinicians with pertinent information that can inform treatment decisions. Related: Liquid Biopsies Help Match Cancer Patients to Phase I Trials.

Gene 105

Gene DNA Life Science Genotype 105

pharmaphorum

MARCH 28, 2022

Via its third call for applications, AION and BioMed X aims to entice innovative thinkers to find ways to develop solutions to common pharma challenges by analysing existing antibody therapies to make new efficient and effective therapies using AI. Then, a development stage or optimisation stage occurs.

Pharma Companies 98

Pharma Companies Antibody Protein Development 98

Scienmag

NOVEMBER 11, 2020

Developed by University of Toronto researchers, the new tool will enable a deeper study of stem cells and other […].

Scientist 98

Scientist Development Research Bioinformatics 98

Scienmag

AUGUST 31, 2020

The project seeks to kickstart the development of an open access “Organoid Cell Atlas” By creating well-characterized in vitro […].

In-Vitro 98

In-Vitro Research Development Bioinformatics 98

Scienmag

JULY 20, 2021

It’s generally accepted to be extinct, the first American insect species destroyed by urban development, but there are lingering questions about whether it was really a species to begin with, or just a […].

DNA 92

DNA Development Bioinformatics Genetics 92

XTalks

MAY 20, 2022

A clinical scientist conducts research to help prevent illness and develops techniques to support patient diagnosis and treatment. They also assist in the testing of medical devices and development of drug products. Genetic Science. To start applying to clinical scientist jobs today, head over to the Xtalks Job Search platform.

Scientist 105

Scientist Life Science Clinical Research Doctors 105

Scienmag

SEPTEMBER 7, 2020

Researchers have developed a statistical model that uses genomic data to predict the risk of developing cancer of the oesophagus Credit: Spence Phillips / EMBL-EBI Oesophageal cancer is the eighth most common cancer worldwide. It often develops from a condition called Barrett’s oesophagus.

Genome 52

Genome Genomics Development Research 52

The Pharma Data

JULY 27, 2021

Amgen (NASDAQ: AMGN) and Teneobio today announced an agreement under which Amgen will acquire Teneobio, a privately held, clinical stage biotechnology company developing a new class of biologics called Human Heavy-Chain Antibodies. executive vice president of Research and Development at Amgen. billion in cash. Reese, M.D.,

Production 52

Production Antibody Sales Development 52

Scienmag

JULY 1, 2021

These fragments–called microRNAs (abbreviated as miRNAs)–have since been shown to be essential at nearly every stage of growth and development in plants, from the production of flowers, stems, […].

RNA 60

RNA Protein Research Gene 60

Scienmag

MARCH 9, 2021

Instead, selection pressures from before widespread use of antibiotics influenced some of them to develop, new research has discovered. By using analytical and sequencing technology that has only been developed in recent years, scientists from Wellcome […].

Bacteria 47

Bacteria Scientist Development Research 47

Scienmag

JANUARY 18, 2021

CopyKAT enables researchers to gain new insights when analyzing solid tumor samples Credit: MD Anderson Cancer Center HOUSTON — In an effort to address a major challenge when analyzing large single-cell RNA-sequencing datasets, researchers from The University of Texas MD Anderson Cancer Center have developed a new computational technique to accurately (..)

RNA 53

RNA Research Development Bioinformatics 53

Scienmag

JUNE 14, 2021

HOUSTON – (June 14, 2021) – In the two decades since the Human Genome Project mapped the entire human genome, improvements in technology have helped in developing updated reference genomes used for sequencing.

Genome 40

Genome Genomics Genome Project Gene 40

Worldwide Clinical Trials

APRIL 7, 2025

Solid tumors exhibit genetic variances between patients with a shared diagnosis and within a single patient, even across one tumor. This variability complicates eligible participant identification and the development of effective treatments, as traditional recruitment methods often result in slow enrollment and high screen-fail rates.

Medicine 100

Medicine Research Clinical Trials Clinical Trials 100

pharmaphorum

SEPTEMBER 16, 2022

With approximately one third of all current FDA-approved drugs targeting GPCRs, Verily/Sosei Heptares are looking to expedite GPCR research within not only immunology, but also gastroenterology and immuno-oncology as well, and the latest data bodes well for future development of therapeutic options in these areas. What, then, is the solution?

Development 135

Development Research Drugs Clinical Trials 135

The Pharma Data

OCTOBER 27, 2020

Research and development expense. The table below summarizes research and development expense by major category (dollars in millions): . Research and development projects. Total research and development expense.

Production 40

Production Sales Licensing Licensing 40

Roots Analysis

AUGUST 15, 2024

These diagnostic solutions are essential for detecting and monitoring diseases, identifying genetic predispositions, and guiding personalized treatment plans. Molecular diagnostic solutions are pivotal across various medical fields, including oncological disorders, infectious diseases, genetic testing, and personalized medicine.

Marketing 40

Marketing Genetics Genome Genomics 40

pharmaphorum

APRIL 7, 2022

Novartis’ generics unit Sandoz has moved on to the next stage of a collaboration with Ares Genetics, which is focusing on the use of artificial intelligence to track antimicrobial resistance (AMR), improve diagnoses and guide the most effective use of antibiotics. “AMR, which is now estimated to directly account for nearly 1.3

Bioinformatics 52

Bioinformatics Genetics Genome Genomics 52

XTalks

NOVEMBER 7, 2022

In addition, Dr. Bahassi stressed that the simple enumeration of CTCs will not contribute significantly to the development of improved or more personalized cancer treatments. During the webinar, Dr. Bahassi gave a brief schematic of how personalized, targeted assays can be developed to detect somatic mutations from cfDNA ( Figure 1 ).

Clinical Trials 98

Clinical Trials Clinical Trials Trials FDA Approval 98

XTalks

DECEMBER 13, 2023

In 2023, biotechnology and pharmaceutical companies leverage cutting-edge technology and significant investments in research and development (R&D) to continue pushing the boundaries of innovation in the healthcare sector, transcending the challenges posed by the pandemic.

Genetics 111

Genetics Vaccination Vaccine DNA 111

The Pharma Data

MAY 22, 2023

Pathogen genomics analyzes the genetic code of viruses, bacteria and other disease-causing organisms to understand how infectious they are, how deadly they are, and how they spread. Diseases do not respect borders: a disease threat in one country is also a threat to others.

Genome 52

Genome Genomics Bioinformatics Bacteria 52

The Pharma Data

JANUARY 10, 2021

His company is leveraging the novel cellular immunotherapy development platform he invented to develop novel, targeted, allogeneic cell therapies against cancer with NK cells, the body’s immune cells that specialize in recognizing and attacking cancer cells. Can we develop…almost a preventative therapeutic approach?

Vaccination 52

Vaccination Vaccine Regulation Drugs 52

STAT News

MARCH 6, 2023

Cambridge-based Moderna recently reported encouraging results from a study of another type of personalized cancer vaccine it developed with the pharmaceutical giant Merck; it uses messenger RNA technology to target advanced melanoma. Therapeutic vaccines represent the next frontier in cancer medicine.

Vaccination 98

Vaccination Vaccine Drugs Clinical Trials 98